Who owns GALMED PHARMACEUTICALS LTD?
- Ticker: GLMD
- CUSIP Number: m47238122
Tip: Access positions for across all investors
Analyze quarterly positions in Galmed Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Galmed Pharmaceuticals stock
Who bought or sold GALMED PHARMACEUTICALS LTD this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Walleye Trading Advisors | 115k | $53k | -54% | Dec 2023 |
|
Two Sigma Advisers | 44k | $20k | -12% | Dec 2023 |
|
Two Sigma Investments | 24k | $11k | -23% | Dec 2023 |
|
Citadel Advisors | 11k | $5.1k | -72% | Dec 2023 |
|
Wells Fargo & Company | 204.00 | $93.003600 | 0% | Dec 2023 |
|
TSFG | 200.00 | $0 | 0% | Mar 2024 |
|
Advisor Group Holdings | 53.00 | $23.998400 | 0% | Dec 2023 |
|
Hanson McClain Advisors | 17.00 | $5.999300 | 0% | Mar 2024 |
|
Zrc Wealth Management | 7.00 | $3.000200 | 0% | Mar 2024 |
|
Bank of America Corporation | 1.00 | $0 | 0% | Dec 2023 |
|
Who sold out of Galmed Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Virtu Financial | Sep 2023 | 30k | $18k |
Millennium Management | Sep 2023 | 20k | $13k |
Bourgeon Capital Management | Dec 2023 | 34.00 | $16.000400 |
UBS Group | Sep 2023 | 28.00 | $16.998800 |